Impingement Syndrome Market Information: By Types (Structural Impingement, Functional Impingement), By Diagnosis (Physical Examination, Imaging), By Treatment (Drug Treatment, Non-Pharmacological Treatment, Surgery), By End Users (Hospitals, Physical Therapists) - Forecast Till 2030

Impingement Syndrome Market Scenario 

Impingement Syndrome Market is expected to reach USD 723.3 Million by 2030 at 7.9% CAGR during the forecast period 2022-2030. Impingement syndrome or subacromial impingement occurs when the tendons of the rotator cuff muscles become impinged and inflamed as they pass through the subacromial space. There are two major types of this disease, structural impingement and functional impingement. Different types of diagnosis methods like bone spurs, rotator cuff injury, labral injury, shoulder instability, biceps tendinopathy and scapula dysfunction can be used to diagnose this disorder. Increasing prevalence of orthopedic diseases, rising geriatric population and changing lifestyle have boosted the growth of the market. According to International Osteoporosis Foundation, worldwide osteoporosis causes more than 8.9 million fractures annually. Moreover, increasing healthcare expenditure and government initiatives for research and development have fuelled the market growth. However, high cost surgeries, and lack of awareness about this disorder may slow the growth of the market.

Impingement Syndrome Market Segmentation          

The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.

On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.

On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is subsegmented into arthroscopic surgery, open surgery and others. On the basis of end user, the market is segmented into hospitals, physical therapists, and others.

Key Players              

Some of the key players in this market are ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US)

Figure: Global Impingement Syndrome Market, by Treatment, 2016 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation

Impingement Syndrome Market Regional Analysis 

The America dominates the global impingement syndrome market owing to the presence of huge geriatric population, increasing number of patient suffering from orthopedic diseases and increasing healthcare expenditure. Moreover, high healthcare speeding is another major factor contributing to the market growth.

Europe accounts for the second largest impingement syndrome market across the globe owing to increasing government support for research & development, increasing investment in healthcare, and well developed healthcare sector.

Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of chronic diseases, huge population base and rapidly developing economy drives the growth of the market in this region.  

The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.

Intended Audience

• Pharmaceutical Companies


• Medical Devices Manufacturer


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors